Results at 28 weeks: Placebo-subtracted weight loss: up to 14.1% (1.2 mg dose) Individual responses: as high as 26.5% Discontinuation rate: 2.9% total, with only 2 of 239 participants stopping due to adverse events The drug showed favorable tolerability compared to current GLP-1s, with lower rates of nausea and vomiting
The study authors measured plasma glucose and insulin levels before the sucrose load and at 30, 60, 90, and 120 min after ingestion
Thyroid 31(1):37 Scarabosio A, Surico PL, Singh RB, Tereshenko V, Musa M, DEsposito F, Russo A, Longo A, Gagliano C, Agosti E (2024) Thyroid eye disease: advancements in orbital and ocular pathology management
Who Bupropion Might Still Make Sense For Bupropion isnt without a legitimate role in weight management
Some formulations separate the products into morning and evening application to avoid stability issues